Rosai-Dorfman disease (RDD) involves abnormal proliferations of oddly behaving histocytes that are not derived from the Langerhan's Cell linage.
stains for S-100, CD1a, CD3 and IgG4. Tissue staining patterns were especially strong for S-100 and the histology demonstrated the unique finding of emperipolesis (Active penetration of one cell by another, both of which remain intact), thus the diagnosis of Rosai-Dorfman disease (RDD) was made (figure 8).
PET-CT was ordered to further characterize the mass and look for possible occult areas of involvement. Flurodeoxyglucose (FDG) uptake was noted in the regions that correlated with the mass on CT. Areas corresponding with the mediastinal mass had a maximal SUV of 9.8 (figure 9) with the atrial septum mass showing an increased SUV of 6.1. No occult lesions were noted.
An implanted pacemaker was placed to address the arrhythmia. However, the patient later experienced a new onset of seizures. MRI imaging was performed to investigate the cause of the seizures and to determine if there were intracranial RDD manifestations. Although not diagnostic of the seizure etiology, MRI studies suggested no intracranial RDD lesions. The patient's condition continues to be monitored, and is without further progression at this time. Due to the general indolent course and frequent spontaneous remission as well as a lack of established treatment, no specific treatment regimen for this patient's RDD has been initiated. The patient continues to do well in follow up.
Rosai-Dorfman disease (RDD), also known as sinus histiocytosis with massive lymphadenopathy (SHML), is a rare and complex disease with a variable presentation and course. Specific incidence and prevalence information is not known for this very rare disease with only about 1000 reported cases worldwide. However, the broader category of histiocytosis type diseases has an incidence of about 3 per million. RDD is one of the rarer anomalies of the hematopoietic system, and presents with diagnostic and classification problems common to histiocytic/dendritic derived diseases. These include the scarcity of histiocyte specific markers, poor determination of monoclonality and overlap with many reactive and infectious processes [1] . Classically RDD presents with cervical lymphadenopathy and secondary cutaneous involvement, however other presentations including extranodal tissue involvement occur [2, 3] . SHML was recognized as a separate entity by Rosai and Dorfman in 1969 [2] , however the pathogenesis of this disease remains elusive even today. Even though there is no clear causative agent in most cases, a link between human herpes virus 6 (HHV-6) and Epstein-Barr virus (EBV) has been suggested, though not conclusively [1, 3] . Although not detected in earlier studies, RDD shows a significant male gender predilection of approximately 4:1 [4, 5, 6]. Of interest is a purely cutaneous variant which occurs much more frequently in older females [5] . The disease most commonly presents in the first three decades of life [1, 7] . However, RDD can present at any age with cases of patients nearing their 8th decade being reported [8] . Literature varies as to whether or not there is any racial disparity in disease occurrence. In the early 1990s, increased frequency in African populations was proposed [6, 9] , as well as in people from the West Indies [4, 6] . Recent reports show the disease to be equally common in those of African and Caucasian descent and less frequent in Asian populations [1] . Recently, association of RDD in concurrence with sickle cell anemia (HbSS) has been reported, although no causal relationship was postulated [6] . Disease progression is generally indolent and spontaneously remits and/or resolves in many cases [3] . This is especially true in cases of purely nodal involvement. Despite generally being considered benign, death has been reported, most frequently from disease involving extra nodal sites in critical organs [3] . Mortality occurs primarily due to compression and disruption of normal tissue function more often than from the disease itself.
Diagnosis of RDD is generally dependent on pathology specimens and immunohistological staining. Even in nodal involvement, the lymph node architecture is usually preserved, with the sinuses expanded by proliferating and often distinctly appearing histiocytes [1], the exact appearance of which can vary from case to case. The key point of light microscopic differentiation from reactive or other proliferative processes is the presence of emperipolesis [1] . This engulfment by histiocytes of lymphocytes, monocytes and even erythrocytes, without subsequent destruction of the cells, is classic for RDD and rarely seen in other disease processes. Regulation and mechanisms of emperipolesis are still being elucidated and may hold promise for future cancer treatment [10] . Immunohistological studies are often employed for diagnosis. RDD usually expresses pan-macrophage antigens; however the strong expression of S-100 is the most helpful marker in diagnosis [1].
Imaging is important in the diagnosis and management of RDD despite generally non-specific findings. Plain film and CT imaging are extremely useful in detecting and characterizing masses, but are not specific for RDD with a wide differential diagnosis including lymphoma and inflammatory and infectious processes [1] . The appearance on CT is one of homogenous masses, frequently with diffusely or locally enlarged lymph nodes [11] . With extranodal disease, CT and MRI findings are also nonspecific and typically reveal polygonal masses, mucosal thickening, or soft-tissue opacification [4] . CT of the head shows RDD lesions to be hyperdense in comparison to grey matter as well as strongly enhancing with contrast [12], while CT of the abdomen yields lesions that are isodense to pancreatic tissue [13, 14] . MRI also typically yields nonspecific results, although it can be very useful to characterize the lesion and exclude other disorders. Lesions of RDD enhance with gadolinium-based contrast agents, showing moderate to slightly increased signal density on T1-weighted imaging but present with variable signal intensity on T2-weighted imaging [11] . A review of central nervous system RDD lesions noted most were visible as isointense relative to gray matter on diffusion-weighted and apparent diffusion coefficient imaging [12] . While these findings again are not unique to RDD, they can be utilized to assist in excluding other disorders [11, 12, 14] . In this reported case, it was determined that new neurologic symptoms were not due to intracranial involvement or progression of RDD.
Systemically, RDD lesions are isointense to skeletal muscle on T1-weighted images but comparatively hyperintense with on T2 imaging [4] . Even though there are no distinguishing features in RDD adenopathy by ultrasound, CT or MRI, RDD lesions are hypermetabolic, thus are predicatively quite positive on positron emission tomography [11] . This increased glucose utilization in RDD allows PET-CT to not only localize tissue involvement not demonstrated on CT alone, but to monitor efficacy of treatment and disease progress [15, 16] . This is a valuable tool as comparisons of patients with confirmed RDD in one anatomical location invariably had involvement at another site [12] , although FDG uptake might be site-variable [4] . In general, earlier detection of subtle site involvement may help determine what if any intervention in indicated, based on the organs involved.
Treatment of RDD may be indicated if there is morbidity due to the specific organ system involved, during disruptive exacerbations or if the case is rapidly progressing. Scenarios such as these are associated with many more complications, including death and occur most frequently in cases presenting with major or primary extranodal involvement [3] . As the causative factor is unknown, and the disease is too rare for randomized case studies of any significant size, treatment efficacy is difficult to determine. Although no definitive link has been established, both EBV and HHV-6 have been postulated as causative [3, 9] with RDD basically a maladaptive reaction to the viral infection. As such it is not surprising that treatment with antiviral drugs has been reported with dramatic success [17] , but with only a sample size of one, and with no follow up trials or studies found. Treatment with various immunosuppressant medications have been used; from high dose steroids to an assortment of chemotherapeutic drugs with overall minimal success at best [3] . Surgical resection of lesions has been far superior to chemotherapy, and in many cases complete resection is curative [3, 13] . In situations where invasive lesions cannot be surgically treated, radiotherapy has been used with some success [3] . Invasion of the myocardium presents with a dilemma of being both poorly resectable and difficult to treat by radiation as well [4, 18] . Invasive cardiac presentation of the disease is very rare with exceptionally few reported cases and a poor prognosis [18, 19, 20] . Difficult to resect disease in extra nodal sites such as intracranial, laryngeal and other locations have shown good response to radiotherapy [21] even if the sample size is small. Although the rarity of the disease limits sample size and inhibits generalizations about efficacy to be drawn, analysis suggests that surgical treatment is generally superior to pharmacological management [1, 3, 13] . Pediatric populations are more likely to have invasive disease [19] , as well as a progressive course. As many of the chemotherapy drugs are themselves carcinogens, course monitoring and surgical control of lesions would seem to be the most prudent course.
Rosai-Dorfman disease is a rare entity and even fewer cases with cardiac involvement being reported. Imaging is important in the diagnosis and management of Rosai-Dorfman disease despite generally non-specific findings. Plain film, CT, and MRI imaging are extremely useful in detecting and characterizing masses, but are not specific for Rosai-Dorfman disease with a wide differential diagnoses including lymphoma, inflammatory and infectious processes. The radiologist should be aware of this rare entity and include it in the differential diagnosis. There is intense hypermetabolism in the mass that surrounds the ascending and the descending aorta. The maximal SUV measured in the mass was 9.8, significantly higher than the blood pool activity.
Etiology
The etiology of RDD is poorly understood at best. There is a suggested link with HHV-6 and EBV but no concrete evidence. Cells with histiocytic linage migrate to lymph nodes and proliferate in a seemingly unregulated manner. This is a distinct entity from Langerhans Cell Histiocytosis with a better prognosis but poorer response to treatment. Emperipolesis is a key feature of RDD, but its function and regulation is not currently understood.
Incidence and prevalence
Specific incidence and prevalence information is not known for this very rare disease with only about 1000 reported cases, however the broader class of histiocytosis type diseases has an incidence of about 3 per million. The disease seems to be less prevalent in persons of Asian descent. Although there is conflicting evidence, RDD may also be more common in those with African descent than Caucasians.
Gender Predilection
There is a strong male gender predilection of approximately 4:1.
Age Predilection
RDD spans all age groups but is most common in the second and third decades of life with a mean age of 20 years at diagnosis.
Risk Factors
There are no clearly defined risk factors for RDD. However extranodal and aggressive disease are more common with a younger presentation.
Treatment
Surgical treatment is the only method with clear efficacy although some success with radiation therapy has been noted and antiviral therapy in early disease holds promise. Chemotherapy is ineffective.
Prognosis RDD generally has a slow course and most cases spontaneously resolve. Extranodal cases are much more aggressive.
Imagining findings
Nonspecific imaging on CT, MRI and US, similar to inflammatory fibrosing lesions. PET with FDG is strongly positive. 
